World Cancer Day is a date that invites us not only to reflect on advances in the fight against this disease but also on how to improve the quality of life for those facing it. Among the many challenges cancer presents, one of the most sensitive is its impact on fertility, especially in young patients who have not yet fulfilled their desire to start a family.
Oncological treatments such as chemotherapy and radiotherapy are highly effective in combating cancer but can damage the reproductive capacity of patients. Cryopreservation of eggs, sperm, and ovarian tissue has become a fundamental technique for preserving fertility before starting these aggressive treatments.
In Spain, it is estimated that around 5.6% of cancer cases diagnosed affect people under 45 years old, according to data from the Spanish Network of Cancer Registries (REDECAN) for 2024 (GEICAM - Cancer figures 2024). This means that approximately 1 in 18 new diagnoses occur in reproductive-age patients, highlighting the importance of considering fertility preservation options as part of comprehensive cancer treatment.
In this context, ReproCopilot plays a fundamental role by providing advanced technologies that facilitate the management and preservation of fertility in oncology patients. However, beyond cryopreservation techniques, the efficient management of medical information is key to ensuring proper follow-up for these patients.
The interoperability of health systems is crucial for the comprehensive management of oncology patients. This is where cloud solutions and Electronic Health Records (EHR) systems come into play. The integration of these systems allows for:
Real-time access to patient information: Healthcare professionals can consult medical histories, test results, and treatment plans from anywhere, facilitating faster and more accurate care.
Better coordination among multidisciplinary teams: Interoperability enables oncologists, fertility specialists, and other healthcare professionals to work together, securely sharing critical information.
Data security and confidentiality: Cloud solutions comply with strict security standards, ensuring the protection of sensitive patient information.
Efficiency in decision-making: The integration of data from different systems facilitates the analysis of clinical information, allowing evidence-based decisions to optimize reproductive health outcomes.
Programs like "Mother After Cancer" by IVI, which has helped nearly 800 oncology patients in Spain preserve their fertility since 2007, are inspiring examples of how reproductive medicine and oncology can come together to offer hope (IVI - Mother After Cancer).
Likewise, institutions such as Dexeus Mujer offer free fertility preservation programs for oncology patients, reaffirming the healthcare sector's commitment to the comprehensive well-being of patients (Dexeus Mujer - Oncological Fertility Preservation).
Fertility preservation in oncology patients is an issue that goes beyond medicine. It is a commitment to hope, to the future, and to the possibility that those who overcome cancer can fulfill their dream of starting a family. At ReproCopilot, we are committed not only to developing advanced technologies but also to creating a more integrated, efficient, and patient-centered healthcare ecosystem.
Because every life counts. And every story deserves to be told.